ADAI News & Events
October 29, 2019
Position Open for ADAI Administrator
ADAI has an outstanding opportunity for an Administrator. This position reports to the Director and is responsible for managing the operations of the institute, financial planning, budget management, grant and contract management, human resources administration, and special projects. As a member of the ADAI Executive Committee, the Administrator participates in policy review and development, long-range…
October 22, 2019
Washington’s Ban on Nicotine Vaping Products is a “Stopgap Public-Health Imperative”
In an op-ed published in the Seattle Times, ADAI research scientist Bia Carlini and WSU professor Laura Hill challenge an earlier column that downplayed the appropriateness of Washington’s ban on nicotine vaping products. Noting the lack of research into these unregulated and widely-available products which have been linked to illnesses in hundreds of individuals and…
“Treat Us Like Human Beings”: New ADAI Report Features Interviews with Syringe Exchange Participants
A new brief from Alison Newman, MPH, Connor Henry, MPH, and Caleb Banta-Green, PhD, MPH, MSW, “Treat us like individual human beings”: 2018 qualitative interviews with Washington State syringe exchange participants,” is now available on our Publications & Reports page. To get a richer understanding of the lives of syringe exchange participants, the authors conducted…
October 18, 2019
Sign Up to Get a Monthly Summary of New Opioid/Overdose Research
Susan Kingston of the Alcohol & Drug Abuse Institute puts out a monthly email newsletter that features the latest in opioid and overdose-related research and commentary. If you’re interested in subscribing, send an email to stopovd@uw.edu. Here’s what was featured in the October 2019 issue: From Local Researchers Engaging an unstably housed population with low-barrier…
October 16, 2019
UW Researchers Receive $40M in NIH Efforts to Address Pain
To address the opioid epidemic, the National Institutes of Health (NIH) launched the HEAL Initiative to support research aimed at helping people with opioid addiction, and exploring safer treatment options for chronic pain. The University of Washington School of Medicine has received multiple awards totaling about $40 million. Included in the HEAL research funding are…
October 4, 2019
Dr. Caleb Banta-Green on “Drugs, Addiction & Recovery”
What do you need to know about substance use disorders and what is the latest science on drugs, addiction, and recovery? Find out from ADAI Senior Research Scientist Caleb Banta-Green, PhD, MPH, MSW, who gave a one-hour presentation to King County prosecutors in September on why people use drugs or alcohol, what substance use disorders…
September 24, 2019
King Co. Behavioral Health Legislative Forum, Nov. 18
Monday, November 18, 2019, 6:00-8:30 p.m. Seattle Center Exhibition Hall – 301 Mercer Street, SeattleFree and Open to All King County’s 2019 Behavioral Health Legislative Forum will include: Opportunities for community members to connect with legislators and county council members before the program. Remarks by King County Executive Dow Constantine. King County’s proposed behavioral health…
September 20, 2019
Marijuana Research Report, 2017 – 2019
ADAI’s new Marijuana Research Report describes our many research studies, collaborations, and dissemination efforts conducted during the 2017-2019 biennium with support from the Washington State Dedicated Marijuana Fund. During this period the Institute supported 8 pilot research studies on marijuana by scientists throughout the UW, bringing the total to 15 small grants funded since 2015,…
September 19, 2019
Peer Support Groups and Medications for OUD
A new ADAI research brief, “Peer Support Groups and Medications for OUD,” written by Alison Newman, MPH, and Caleb Banta-Green, PhD, MPH, MSW, is now available on our Publications & Reports page. For this brief, ADAI surveyed people with opioid use disorder and care providers who work with them to find out more about their…
August 15, 2019
CBD Confusion: UW Experts Urge Research to Clarify Claims
An op-ed published today by ADAI senior scientist Bia Carlini, PhD, MPH, Dr. Greg Carter, and pharmacology professor Nephi Stella points to the dearth of science-based information about the rapidly proliferating products containing CBD (cannabidiol) — a non-intoxicating component found in cannabis and hemp. “Today, cannabis is federally criminalized and research into its potential medical…
Previous page Next page
